|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-17
|
|
pubmed:abstractText |
Shipment of therapeutic somatic cells between a current good manufacturing practice (cGMP) facility and a clinic or between different cGMP facilities requires validated standard operating procedures (SOP). Under National Heart Lung & Blood Institute (NHLBI) sponsorship, the Production Assistance for Cellular Therapies (PACT) group conducted a validation study for the shipping SOP it has created, including shipments of cryopreserved somatic cells, fresh peripheral blood specimens and apheresis products.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1477-2566
|
|
pubmed:author |
pubmed-author:DurettAprilA,
pubmed-author:GeeAdrianA,
pubmed-author:GoodingWilliamW,
pubmed-author:GriffinDeborah LDL,
pubmed-author:KadidloDianeD,
pubmed-author:LindbladRobertR,
pubmed-author:McKennaDavidD,
pubmed-author:StansonJoannaJ,
pubmed-author:StyersDavidD,
pubmed-author:SumstadDarinD,
pubmed-author:WhitesideTheresa LTL,
pubmed-author:WoodDeborahD
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
201-13
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Shipping of therapeutic somatic cell products.
|
|
pubmed:affiliation |
University of Pittsburgh, Pittsburgh, Pennsylvania, USA. whitesidetl@upmc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural,
Validation Studies
|
